[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]

Скачать 217.57 Kb.
Название[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense]
Размер217.57 Kb.
1   2   3   4   5   6   7   8
FEMS Immunol Med Microbiol 43 (3): 367-372, 2005

Scalise I; Durantini EN. Synthesis, properties, and photodynamic inactivation of Escherichia coli using a cationic and a noncharged Zn(II) pyridyloxyphthalocyanine derivatives. Bioorg Med Chem 13 (8): 3037-3045, 2005

Schaffer M; Ertl-Wagner B; Schaffer PM; Kulka U; Jori G; Duhmke E; Hofstetter A. The Application of Photofrin II as a sensitizing agent for ionizing radiation--a new approach in tumor therapy? Curr Med Chem 12 (10): 1209-1215, 2005

Schastak S; Jean B; Handzel R; Kostenich G; Hermann R; Sack U; Orenstein A; Wang YS; Wiedemann P. Improved pharmacokinetics, biodistribution and necrosis in vivo using a new near infra-red photosensitizer: tetrahydroporphyrin tetratosylat. J Photochem Photobiol B 78 (3): 203-213, 2005

Schein OD; Bressler NM; Price P. Photodynamic therapy with verteporfin: observations on the introduction of a new treatment into clinical practice. Arch Ophthalmol 123 (1): 58-63, 2005

Schill D. [Improved survival following photodynamic therapy]. Med Monatsschr Pharm 28 (8): 294, 2005

Schmidt-Erfurth U; Michels S; Indorf L; Eggers R; Birngruber R. Mechanism of photodynamic occlusion using liposomal Zn(II)-phtalocyanine. Curr Eye Res 30 (7): 601-612, 2005

Schmidt D. [Retinal angiomatosis]. Klin Monatsbl Augenheilkd 222 (2): 90-109, 2005

Schmook T; Budde K; Ulrich C; Neumayer HH; Fritsche L; Stockfleth E. Successful treatment of nephrogenic fibrosing dermopathy in a kidney transplant recipient with photodynamic therapy. Nephrol Dial Transplant 20 (1): 220-222, 2005

Schneider R; Schmitt F; Frochot C; Fort Y; Lourette N; Guillemin F; Muller JF; Barberi-Heyob M. Design, synthesis, and biological evaluation of folic acid targeted tetraphenylporphyrin as novel photosensitizers for selective photodynamic therapy. Bioorg Med Chem 13 (8): 2799-2808, 2005

Schnurrbusch UE; Jochmann C; Einbock W; Wolf S. Complications after photodynamic therapy. Arch Ophthalmol 123 (10): 1347-1350, 2005

Schnurrbusch UE; Jochmann C; Wiedemann P; Wolf S. Quantitative assessment of the long-term effect of photodynamic therapy in patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 243 (8): 829-833, 2005

Schroeter CA; Pleunis J; Nispen tot PC; Reineke T; Neumann HA. Photodynamic therapy: new treatment for therapy-resistant plantar warts. Dermatol Surg 31 (1): 71-75, 2005

Sedlmaier B; Franke A; Sudhoff H; Jovanovic S; Haisch A. Photodynamic effect of argon and diode laser on cholesteatoma cell cultures after intravital staining with absorption enhancers. Lasers Med Sci 19 (4): 248-256, 2005

Senior K. Photodynamic therapy for bladder cancer. Lancet Oncol 6 (8): 546, 2005

Seshadri M; Spernyak JA; Mazurchuk R; Camacho SH; Oseroff AR; Cheney RT; Bellnier DA. Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy. Clin Cancer Res 11 (11): 4241-4250, 2005

Shah GK; Blinder KJ; Hariprasad SM; Thomas MA; Ryan EH, Jr.; Bakal J; Sharma S. Photodynamic therapy for juxtafoveal choroidal neovascularization due to ocular histoplasmosis syndrome. Retina 25 (1): 26-32, 2005

Shanmugam MP; Agarwal M. RPE atrophy following photodynamic therapy in type 2A idiopathic parafoveal telangiectasis. Indian J Ophthalmol 53 (1): 61-63, 2005

Sharma M; Sahu K; Dube A; Gupta PK. Extracellular pH influences the mode of cell death in human colon adenocarcinoma cells subjected to photodynamic treatment with chlorin p6. J Photochem Photobiol B 81 (2): 107-113, 2005

Sharma M; Bansal H; Gupta PK. Virulence of Pseudomonas aeruginosa cells surviving photodynamic treatment with toluidine blue. Curr Microbiol 50 (5): 277-280, 2005

Sharma S; Bakal J; Sharma SM; Covert D; Shah GK. Drug pricing for a novel treatment for wet macular degeneration: using incremental cost-effectiveness ratios to ensure societal value. Can J Ophthalmol 40 (3): 369-377, 2005

Sharman WM; van Lier JE. Synthesis and photodynamic activity of novel asymmetrically substituted fluorinated phthalocyanines. Bioconjug Chem 16 (5): 1166-1175, 2005

Shen XY; Zacal N; Singh G; Rainbow AJ. Alterations in mitochondrial and apoptosis-regulating gene expression in photodynamic therapy-resistant variants of HT29 colon carcinoma cells. Photochem Photobiol 81 (2): 306-313, 2005

Shields CL; Materin MA; Marr BP; Mashayekhi A; Shields JA. Resolution of advanced cystoid macular edema following photodynamic therapy for choroidal hemangioma. Ophthalmic Surg Lasers Imaging 36 (3): 237-239, 2005

Shikowitz MJ; Abramson AL; Steinberg BM; DeVoti J; Bonagura VR; Mullooly V; Nouri M; Ronn AM; Inglis A; McClay J; Freeman K. Clinical trial of photodynamic therapy with meso-tetra (hydroxyphenyl) chlorin for respiratory papillomatosis. Arch Otolaryngol Head Neck Surg 131 (2): 99-105, 2005

Shim CS. [Photodynamic therapy in gastroenterology]. Korean J Gastroenterol 45 (3): 153-161, 2005

Shim CS; Cheon YK; Cha SW; Bhandari S; Moon JH; Cho YD; Kim YS; Lee LS; Lee MS; Kim BS. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 37 (5): 425-433, 2005

Shyong MP; Lee FL; Chen SJ; Tung TH; Tsai DC; Hsu WM. Photodynamic therapy for subfoveal choroidal neovascularization secondary to age-related macular degeneration. J Chin Med Assoc 68 (9): 419-424, 2005

Siersema PD. Endoscopic therapeutic esophageal interventions: what is new? What needs further study? What can we forget? Curr Opin Gastroenterol 21 (4): 490-497, 2005

Siersema PD. Photodynamic therapy for Barrett's esophagus: not yet ready for the premier league of endoscopic interventions. Gastrointest Endosc 62 (4): 503-507, 2005

Siewerdsen JH; Moseley DJ; Burch S; Bisland SK; Bogaards A; Wilson BC; Jaffray DA. Volume CT with a flat-panel detector on a mobile, isocentric C-arm: pre-clinical investigation in guidance of minimally invasive surgery. Med Phys 32 (1): 241-254, 2005

Sigusch BW; Pfitzner A; Albrecht V; Glockmann E. Efficacy of photodynamic therapy on inflammatory signs and two selected periodontopathogenic species in a beagle dog model. J Periodontol 76 (7): 1100-1105, 2005

Silva RM; Figueira J; Cachulo ML; Duarte L; Faria dA, Jr.; Cunha-Vaz JG. Polypoidal choroidal vasculopathy and photodynamic therapy with verteporfin. Graefes Arch Clin Exp Ophthalmol 243 (10): 973-979, 2005

Silva VM; Corson N; Elder A; Oberdorster G. The rat ear vein model for investigating in vivo thrombogenicity of ultrafine particles (UFP). Toxicol Sci 85 (2): 983-989, 2005

Sim HG; Lau WK; Olivo M; Tan PH; Cheng CW. Is photodynamic diagnosis using hypericin better than white-light cystoscopy for detecting superficial bladder carcinoma? BJU Int 95 (9): 1215-1218, 2005

Singh AD; Talbot JF; Rundle PA; Rennie IG. Choroidal neovascularization secondary to choroidal osteoma: successful treatment with photodynamic therapy. Eye 19 (4): 482-484, 2005

Singh AD; Rundle PA; Vardy SJ; Rennie IG. Photodynamic therapy of choroidal haemangioma associated with Sturge-Weber syndrome. Eye 19 (3): 365-367, 2005

Singhal D; van Gulik TM; Gouma DJ. Palliative management of hilar cholangiocarcinoma. Surg Oncol 14 (2): 59-74, 2005

Sirica AE. Cholangiocarcinoma: molecular targeting strategies for chemoprevention and therapy. Hepatology 41 (1): 5-15, 2005

Sivaprasad S; Saleh GM; Jackson H. Does lesion size determine the success rate of photodynamic therapy for age-related macular degeneration? Eye , 2005

Sivaprasad S; Hammond CJ; Jackson H. Photodynamic therapy for age-related macular degeneration. Eye 19 (9): 1027-1028, 2005

Skrzypczak-Jankun E; Borbulevych OY; Melillo A; Keck R; Soriano-Garcia M; Aniola J; Niedre M; Lilge L; Selman SH; Jankun J. Aspirin blocks binding of photosensitizer SnET2 into human serum albumin: implications for photodynamic therapy. Int J Mol Med 15 (5): 777-783, 2005

Skyrme RJ; French AJ; Datta SN; Allman R; Mason MD; Matthews PN. A phase-1 study of sequential mitomycin C and 5-aminolaevulinic acid-mediated photodynamic therapy in recurrent superficial bladder carcinoma. BJU Int 95 (9): 1206-1210, 2005

Smucler R; Jatsova E. Comparative study of aminolevulic acid photodynamic therapy plus pulsed dye laser versus pulsed dye laser alone in treatment of viral warts. Photomed Laser Surg 23 (2): 202-205, 2005

Sol V; Lamarche F; Enache M; Garcia G; Granet R; Guilloton M; Blais JC; Krausz P. Polyamine conjugates of meso-tritolylporphyrin and protoporphyrin IX: Potential agents for photodynamic therapy of cancers. Bioorg Med Chem , 2005

Solban N; Ortel B; Pogue B; Hasan T. Targeted optical imaging and photodynamic therapy. Ernst Schering Res Found Workshop (49): 229-258, 2005

Solomon SD; Bressler SB; Hawkins BS; Marsh MJ; Bressler NM. Guidelines for interpreting retinal photographs and coding findings in the Submacular Surgery Trials (SST): SST report no. 8. Retina 25 (3): 253-268, 2005

Song K; Kong B; Qu X; Li L; Yang Q. Phototoxicity of Hemoporfin to ovarian cancer. Biochem Biophys Res Commun 337 (1): 127-132, 2005

Souied EH; Pawlak D; Algan M; Sayag D; Coscas G; Soubrane G. Photodynamic therapy for choroidal neovascularization on late-onset fundus flavimaculatus. Am J Ophthalmol 140 (2): 312-314, 2005

Souza CS; Felicio LB; Bentley MV; Tedesco AC; Ferreira J; Kurachi C; Bagnato VS. Topical photodynamic therapy for Bowen's disease of the digit in epidermolysis bullosa. Br J Dermatol 153 (3): 672-674, 2005

Spaide RF; Sorenson J; Maranan L. Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization. Retina 25 (6): 685-690, 2005

Spaide RF; Sorenson J; Maranan L. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization. Ophthalmology 112 (2): 301-304, 2005

Spesia MB; Lazzeri D; Pascual L; Rovera M; Durantini EN. Photoinactivation of Escherichia coli using porphyrin derivatives with different number of cationic charges. FEMS Immunol Med Microbiol 44 (3): 289-295, 2005

Steluti R; De Rosa FS; Collett J; Tedesco AC; Bentley MV. Topical glycerol monooleate/propylene glycol formulations enhance 5-aminolevulinic acid in vitro skin delivery and in vivo protophorphyrin IX accumulation in hairless mouse skin. Eur J Pharm Biopharm 60 (3): 439-444, 2005

Stoltz RA; Glazer-Hockstein C; Tolentino MJ; Maguire AM. Transmission of retinal laser wavelengths through blood. Retina 25 (4): 498-502, 2005

Storen T; Royset A; Svaasand LO; Lindmo T. Functional imaging of dye concentration in tissue phantoms by spectroscopic optical coherence tomography. J Biomed Opt 10 (2): 024037, 2005

Strauss RM; Pollock B; Stables GI; Goulden V; Cunliffe WJ. Photodynamic therapy using aminolaevulinic acid does not lead to clinical improvement in hidradenitis suppurativa. Br J Dermatol 152 (4): 803-804, 2005

Stylli SS; Kaye AH; Macgregor L; Howes M; Rajendra P. Photodynamic therapy of high grade glioma - long term survival. J Clin Neurosci 12 (4): 389-398, 2005

Swinson B; Jerjes W; El Maaytah M; Norris P; Hopper C. Optical techniques in diagnosis of head and neck malignancy. Oral Oncol , 2005

Sylantiev C; Schoenfeld N; Mamet R; Groozman GB; Drory VE. Acute neuropathy mimicking porphyria induced by aminolevulinic acid during photodynamic therapy. Muscle Nerve 31 (3): 390-393, 2005

Szabo A; Gehl Z; Seres A. Photodynamic (verteporfin) therapy for retinal capillary haemangioma, with monitoring of feeder and draining blood vessel diameters. Acta Ophthalmol Scand 83 (4): 512-513, 2005

Takahashi H; Nakajima S; Sakata I; Ishida-Yamamoto A; Iizuka H. ATX-S10(Na)-photodynamic therapy is less carcinogenic for mouse skin compared with ultraviolet B irradiation. Br J Dermatol 153 (6): 1182-1186, 2005

Takahashi H; Nakajima S; Sakata I; Ishida-Yamamoto A; Iizuka H. Photodynamic therapy using a novel photosensitizer, ATX-S10(Na): comparative effect with 5-aminolevulinic acid on squamous cell carcinoma cell line, SCC15, ultraviolet B-induced skin tumor, and phorbol ester-induced hyperproliferative skin. Arch Dermatol Res 296 (10): 496-502, 2005

Takeda H; Kaneko T; Harada K; Matsuzaki Y; Nakano H; Hanada K. Successful treatment of lymphadenosis benigna cutis with topical photodynamic therapy with delta-aminolevulinic acid. Dermatology 211 (3): 264-266, 2005

Tamosiunas M; Bagdonas S; Didziapetriene J; Rotomskis R. Electroporation of transplantable tumour for the enhanced accumulation of photosensitizers. J Photochem Photobiol B 81 (2): 67-75, 2005

Tang W; Xu H; Kopelman R; Philbert MA. Photodynamic characterization and in vitro application of methylene blue-containing nanoparticle platforms. Photochem Photobiol 81 (2): 242-249, 2005

Tarstedt M; Rosdahl I; Berne B; Svanberg K; Wennberg AM. A randomized multicenter study to compare two treatment regimens of topical methyl aminolevulinate (Metvix)-PDT in actinic keratosis of the face and scalp. Acta Derm Venereol 85 (5): 424-428, 2005

Tegos GP; Demidova TN; Arcila-Lopez D; Lee H; Wharton T; Gali H; Hamblin MR. Cationic fullerenes are effective and selective antimicrobial photosensitizers. Chem Biol 12 (10): 1127-1135, 2005

Thissen MR; Kuijpers DI; Neumann HA. [The wider application of photodynamic therapy in dermatology]. Ned Tijdschr Geneeskd 149 (5): 232-237, 2005

Thompson MS; Johansson A; Johansson T; Andersson-Engels S; Svanberg S; Bendsoe N; Svanberg K. Clinical system for interstitial photodynamic therapy with combined on-line dosimetry measurements. Appl Opt 44 (19): 4023-4031, 2005

Thong PS; Watt F; Ren MQ; Tan PH; Soo KC; Olivo M. Hypericin-photodynamic therapy (PDT) using an alternative treatment regime suitable for multi-fraction PDT. J Photochem Photobiol B , 2005

Till H; Bergmann F; Metzger R; Haeberle B; Schaeffer K; von Schweinitz D; Prosst RL. Videoscopic fluorescence diagnosis of peritoneal and thoracic metastases from human hepatoblastoma in nude rats. Surg Endosc , 2005

Tiwari A; Krishna NS; Nanda K; Chugh A. Benign prostatic hyperplasia: an insight into current investigational medical therapies. Expert Opin Investig Drugs 14 (11): 1359-1372, 2005

Triadafilopoulos G. Photodynamic therapy for the treatment of patients with Barrett's high-grade dysplasia and mucosal adenocarcinoma. Nat Clin Pract Gastroenterol Hepatol 2 (3): 136-137, 2005

Triesscheijn M; Ruevekamp M; Aalders M; Baas P; Stewart FA. Outcome of mTHPC Mediated Photodynamic Therapy is Primarily Determined by the Vascular Response. Photochem Photobiol 81 (5): 1161-1167, 2005

Tsai JC; Wu CL; Chien HF; Chen CT. Reorganization of cytoskeleton induced by 5-aminolevulinic acid-mediated photodynamic therapy and its correlation with mitochondrial dysfunction. Lasers Surg Med 36 (5): 398-408, 2005

Tsujino I; Miyagi K; Sampson R; Sieber F. Potentiation of the Anti-Tumor Effect of Merocyanine 540-Mediated Photodynamic Therapy by Amifostine and Amphotericin B.
1   2   3   4   5   6   7   8


[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSelected Anomalies and Diseases of the Eye

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconHepatic Liver Diseases – Methods for Diagnosis and

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconAbengoechea-hernandez, S., Elizalde-montagut, J. & Fideliz de la paz-dalisay, M. (2007) [Photodynamic therapy in adult-onset foveomacular vitelliform

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconБад «нагипол» в терапии алиментарно-зависимых патологий. Baa "nagipol" in therapy alimentary-dependent’s diseases
Ключевые слова: биологически-активная добавка (бад), пивные дрожжи, автолизат, алиментарно-зависимые патологии, витамины, аминокислоты,...
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEndometriosis. Gynaecological diseases of children and teenagers
[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconSession 2: Fourier Transform Infrared (ft ir) & Fluorescence Spectroscopy

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconThe American Occupational Therapy Foundation & American Occupational Therapy Association’s

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon2. Device choice

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] icon“Assistive Device for Calendar Production”

[A device for fluorescence diagnosis and photodynamic therapy of eye diseases, by using photosense] iconEye Tracking and e-Learning

Разместите кнопку на своём сайте:

База данных защищена авторским правом ©lib.znate.ru 2014
обратиться к администрации
Главная страница